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Abstract 32 
 33 
Caffeine (1, 3, 7-trimethylxanthine) has been implicated in the regulation of glucose 34 
and lipid metabolism including actions such as insulin-independent glucose transport, 35 
glucose transporter (GLUT) 4 expression, and fatty acid utilization in skeletal 36 
muscle.  These effects are similar to the exercise-induced and 5’AMP-activated 37 
protein kinase (AMPK)-mediated metabolic changes in skeletal muscle, suggesting 38 
that caffeine is involved in the regulation of muscle metabolism through AMPK 39 
activation.  We explored whether caffeine acts on skeletal muscle to stimulate 40 
AMPK.  Incubation of rat epitrochlearis and soleus muscles with Krebs buffer 41 
containing caffeine (≥ 3 mmol/L, ≥ 15 min) increased the phosphorylation of 42 
AMPKα Thr172, an essential step for full kinase activation, and acetyl CoA 43 
carboxylase Ser79, a downstream target of AMPK, in dose- and time-dependent 44 
manners.  Analysis of isoform-specific AMPK activity revealed that both AMPKα1 45 
and α2 activities increased significantly.  This enzyme activation was associated 46 
with a reduction in phosphocreatine content and an increased rate of 47 
3-O-methyl-D-glucose transport activity in the absence of insulin.  These results 48 
suggest that caffeine has similar actions to exercise, by acutely stimulating skeletal 49 
muscle AMPK activity and insulin-independent glucose transport with a reduction of 50 
the intracellular energy status. 51 
52 
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1. Introduction 53 
 54 
Skeletal muscle is the major site of whole-body glucose transport and 55 
metabolism.  Insulin and exercise (contractile activity) are the most potent and 56 
physiologically relevant stimuli of glucose transport, the rate-limiting step in glucose 57 
utilization under physiological conditions [1,2].  Similar to insulin stimulation, 58 
exercise acutely increases the rate of glucose transport into contracting skeletal 59 
muscle by the translocation of glucose transporter (GLUT) 4 to the plasma 60 
membrane and transverse tubules.  However, a growing body of data indicates that 61 
exercise and insulin use distinct signaling pathways in skeletal muscle, and 62 
5’AMP-activated protein kinase (AMPK) has been identified as part of the 63 
mechanisms leading to exercise-stimulated glucose transport (reviewed in [3-5]). 64 
Skeletal muscle AMPK is also implicated in a variety of antidiabetic properties 65 
of exercise, including GLUT4 expression [6,7], glycogen regulation [8,9], fatty acid 66 
oxidation [10,11], and enhanced insulin sensitivity [7,12,13].  In addition, skeletal 67 
muscle AMPK mediates part of glucose and lipid homeostasis by adipokines, 68 
including leptin and adiponectin, and the hypoglycemic effect of metformin 69 
(reviewed in [3-5]).  Thus, through these metabolic effects in skeletal muscle, 70 
AMPK fosters a metabolic milieu that may reduce the risk for type 2 diabetes. 71 
Caffeine (1, 3, 7-trimethylxanthine) has been implicated in the regulation of 72 
glucose and lipid metabolism in skeletal muscle.  Caffeine stimulates muscle 73 
glucose transport in the absence of insulin in rodents [14-16], increases GLUT4 74 
mRNA or protein expression in cultured myotubes [17,18], and enhances fatty acid 75 
metabolism in perfused rat skeletal muscles [19].  These effects are similar to the 76 
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exercise-induced and AMPK-mediated metabolic changes in skeletal muscle, 77 
suggesting that caffeine regulates muscle metabolisms through AMPK activation.   78 
AMPK is a heterotrimeric kinase, consisting of a catalytic α-subunit and two 79 
regulatory subunits, β and γ.  Two distinct α-isoforms (α1 and α2) exist in skeletal 80 
muscle [20].  A recent study by Jensen et al [16] demonstrated that caffeine acutely 81 
stimulates AMPKα1 activity, but not α2 activity, in incubated mouse and rat soleus 82 
muscles.  However, they did not observe significant phosphorylation on AMPKα 83 
Thr172, an essential step for full kinase activation [21].  Similarly, Wright et al [14] 84 
and Canto et al [15] also reported that caffeine has no effect on AMPKα Thr172 85 
phosphorylation in incubated rat skeletal muscles, but they did not measure AMPK 86 
activity.  In contrast, Raney et al [19] demonstrated that caffeine increases 87 
AMPKα2 activity in perfused rat hindlimb muscles, but they did not measure 88 
AMPKα Thr172 phosphorylation. 89 
The purpose of the present study was to reevaluate whether caffeine has the 90 
potential to act on skeletal muscle and stimulate AMPK.  For this purpose, we used 91 
an isolated rat skeletal muscle preparation to eliminate the effects of systemic 92 
confounders such as circulatory, humoral and neural factors, and of intestinal 93 
absorption of caffeine.  We determined the effect of caffeine on AMPKα Thr172 94 
phosphorylation as well as on α1 and α2 isoform-specific AMPK activities in 95 
fast-twitch epitrochlearis and slow-twitch soleus muscles in vitro.   96 
97 
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2. Materials and Methods 98 
 99 
2.1. Animals 100 
Ninety-seven male Sprague-Dawley rats weighing 100 g were obtained from 101 
Shimizu Breeding Laboratories (Kyoto, Japan).  Animals were housed in an animal 102 
room maintained at 22-24°C with a 12:12-h light-dark cycle and fed a standard 103 
laboratory diet (Certified Diet MF; Oriental Koubo, Tokyo, Japan) and water ad 104 
libitum.  Rats were fasted overnight before the experiments and were randomly 105 
assigned to the experimental groups.  All protocols for animal use and euthanasia 106 
were reviewed and approved by the Kyoto University Graduate School of Human 107 
and Environmental Studies, Kyoto University Graduate School of Medicine, and 108 
Kyoto University Radioisotope Research Center in Japan. 109 
 110 
2.2. Muscle incubation 111 
Two muscles, epitrochlearis and soleus, were chosen due to their specific fiber 112 
type composition.  The epitrochlearis is composed predominantly of fast-twitch 113 
glycolytic fibers (60-65% fast-twitch white, 20% fast-twitch red, 15% slow-twitch 114 
red) [22], and the soleus is composed primarily of slow-twitch oxidative fibers (0% 115 
fast-twitch white, 13% fast-twitch red, 87% slow-twitch red) [23].   116 
Muscles were treated as we described previously [24,25].  Rats were sacrificed 117 
by cervical dislocation without anesthesia, and the muscles of each side were rapidly 118 
removed.  Both ends of each muscle were tied with sutures (silk 3-0; Natsume 119 
Seisakusho, Tokyo, Japan) and the muscles were mounted on an incubation 120 
apparatus with a tension set to 0.5 g.  The buffers were continuously gassed with 121 
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95% O2-5% CO2 and maintained at 37°C.  Muscles were preincubated in 7 mL of 122 
Krebs-Ringer bicarbonate buffer (KRB) (117 mmol/L NaCl, 4.7 mmol/L KCl, 2.5 123 
mmol/L CaCl2, 1.2 mmol/L KH2PO4, 1.2 mmol/L MgSO4, 24.6 mmol/L NaHCO3) 124 
containing 2 mmol/L pyruvate (KRBP) for 40 min.  For the time- and 125 
dose-dependent effects of caffeine, muscles were then randomly assigned to 126 
incubation in 7 mL of fresh buffer in the presence of 3 mmol/L caffeine for up to 60 127 
min, or in 7 mL of fresh buffer in the absence or presence of 1-15 mmol/L caffeine 128 
for 15 min, respectively.  Immediately after incubation, muscles were frozen in 129 
liquid nitrogen, weighed, and stored at –80°C, and then subjected to Western blot 130 
analysis for phosphorylated AMPKα, total AMPKα, phosphorylated acetyl CoA 131 
carboxylase (ACC) and total ACC.  The wet muscle weight of epitrochlearis and 132 
soleus were 12.6 ± 3.0 (mean ± SD, n=152) mg and 35.4 ± 7.9 (mean ± SD, n=145) 133 
mg, respectively.  Some frozen muscles collected for the time-dependent effect 134 
were subjected to measurements for adenosine triphosphate (ATP), phosphocreatine 135 
(PCr) (see ATP and PCr Assay) and glycogen (see Muscle glycogen content) content.  136 
For other experiments we incubated muscles in the absence or presence of 3 mmol/L 137 
caffeine for 15 min (see RESULTS).  Immediately after incubation, some muscles 138 
were used for the measurement of glucose transport activity (see 139 
3-O-methyl-D-glucose transport), and others were frozen in liquid nitrogen, stored at 140 
–80°C, and analyzed for isoform-specific AMPK activity or Western blot analysis 141 
for GLUT4. 142 
 143 
2.3. Western blot analysis 144 
Sample preparation and Western blot analysis for detection of phosphorylated 145 
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AMPKα, total AMPKα, phosphorylated ACC, and total ACC were performed as we 146 
described previously [25].  Muscles were homogenized in ice-cold lysis buffer 147 
(1:40 wt/vol) containing 20 mmol/L Tris·HCl (pH 7.4), 1% Triton X, 50 mmol/L 148 
NaCl, 250 mmol/L sucrose, 50 mmol/L NaF, 5 mmol/L sodium pyrophosphate, 2 149 
mmol/L dithiothreitol, 4 mg/L leupeptin, 50 mg/L trypsin inhibitor, 0.1 mmol/L 150 
benzamidine, and 0.5 mmol/L phenylmethylsulfonyl fluoride and centrifuged at 151 
16,000 g for 40 min at 4°C.  Lysates were solubilized in Laemmli’s sample buffer 152 
containing mercaptoethanol and boiled.   153 
Sample preparation and Western blot analysis for detection of GLUT4 were 154 
performed as we described previously [13].  Muscles were homogenized in ice-cold 155 
buffer containing 250mmol/L sucrose, 20 mmol/L 156 
2-[4-(2-hydroxyethyl)-1-piperadinyl] ethonsulforic acid (HEPES) (pH 7.4), and 1 157 
mmol/L EDTA, and centrifuged at 1200 g for 5 minutes.  The supernatant was 158 
centrifuged at 200, 000 g for 60 minutes at 4°C.  The resulting pellet was 159 
solubilized in Laemmli’s sample buffer containing dithiothreitol.   160 
The samples (10 µg of protein) were separated on either 10% polyacrylamide gel 161 
for AMPK and GLUT4 or 7.5% gel for ACC.  Proteins were then transferred to 162 
polyvinylidene difluoride membranes (PolyScreen; PerkinElmer, Wellesley, MA) at 163 
100 V for 1 h.  Membranes were blocked for 1h at room temperature in TBS-T 164 
(TBS with 0.1% Tween 20) containing 5% nonfat dry milk and were then incubated 165 
over night at 4°C with phosphospecific AMPKα Thr172 (#2531; Cell Signaling 166 
Technology, Beverly, MA) diluted 1:1000, AMPKα (#2532; Cell Signaling 167 
Technology, Beverly, MA) diluted 1:1000, phosphospecific ACC Ser79 (#07-303; 168 
Upstate Biotechnology, Lake Placid, NY) diluted 1:1000, ACC (#3662; Cell 169 
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Signaling Technology, Beverly, MA) diluted 1:1000, or GLUT4 (#4670-1704; 170 
Biogenesis; South Coast, United Kingdom) diluted 1:2000.  The membranes were 171 
then washed, incubated for 1h at room temperature with anti-mouse IgG antibody 172 
(GE Healthcare, Buckinghamshire, UK) diluted 1:2500, and developed with 173 
enhanced chemiluminescence reagents according to the manufacturer's instructions 174 
(Amersham Biosciences, Buckinghamshire, UK).  The intensity of the signals was 175 
quantified using Multi-Analyst software (Bio-Rad, Hercules, CA).  The mean 176 
intensity of control samples in each membrane was used as reference for controlling 177 
gel-to-gel variation.  Equal protein loading and transfer was confirmed by 178 
Coomassie brilliant blue staining of the membranes.   179 
 180 
2.4. Isoform-specific AMPK activity assay 181 
We have raised AMPK polyclonal antibodies in rabbit against isoform-specific 182 
peptides derived from the amino acid sequences of rat α1 (residues 339–358) or α2 183 
(residues 490–514) [25].  AMPK activity assay was performed as we described 184 
previously [25,26].  Muscles were homogenized as described in Western blot 185 
analysis, and resultant supernatants (100 µg of protein) were immunoprecipitated 186 
with the α1 or α2 AMPK antibody and protein A-Sepharose beads (Amersham 187 
Biosciences, Uppsala, Sweden).  Immunoprecipitates were washed twice both in 188 
lysis buffer and in wash buffer (240 mmol/L HEPES and 480 mmol/L NaCl).  189 
Kinase reactions were performed in 40 HEPES (pH 7.0), 0.1 mmol/L SAMS peptide 190 
[25,26], 0.2 mmol/L AMP, 80 mmol/L NaCl, 0.8 mmol/L dithiothreitol, 5 mmol/L 191 
MgCl2, 0.2 mmol/L ATP (2 µCi of [γ-32P] ATP) (PerkinElmer, Wellesley, MA), in a 192 
final volume of 40 µl for 20 min at 30°C.  At the end of the reaction, a 15-µl aliquot 193 
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was removed and spotted onto Whatman P81 paper (Whatman International, 194 
Maidstone, UK).  The papers were washed six times in 1% phosphoric acid and 195 
once in acetone. 32P incorporation was quantitated with a scintillation counter, and 196 
kinase activity was expressed as fold increases relative to the control samples.   197 
 198 
2.5. ATP and PCr assay 199 
ATP and PCr content were measured fluorometrically in perchloric acid extracts 200 
of epitrochlearis and soleus muscles according to the method of Lowry and 201 
Passonneau [27].  In brief, each frozen muscle was homogenized in 0.2 mol/L 202 
HClO4 (3:25 w/v) in an ethanol-dry ice bath (-20 ~ -30°C) and centrifuged at 16,000 203 
g for 2 min at -9°C.  The supernatant of the homogenate was neutralized with a 204 
solution of 2 mol/L KOH, 0.4 mol/L KCl and 0.4 mol/L imidazole and then 205 
centrifuged at 16,000 g for 2 min at -9°C, and then subjected to enzymatic analysis 206 
[27].  ATP and PCr content were expressed as nanomoles per milligram wet weight 207 
of muscle. 208 
 209 
2.6. Muscle glycogen content 210 
Glycogen content was assayed as we described previously [7,9].  Each frozen 211 
muscle was digested in 1 mol/L NaOH at 85°C for 10 minutes, and the digestates 212 
were neutralized with HCl.  The glycogen in the digestates was hydrolyzed by 213 
incubated in 2 mol/L HCL for 2 h at 85°C.  The digestates were neutralized with 214 
NaOH, and the concentration of hydrolyzed glucose residues was measured 215 
enzymatically using Glucose CII Test (Wako, Osaka, Japan).  Glycogen content 216 
was expressed as nanomoles of glucose per milligram wet weight of muscle. 217 
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 218 
2.7. 3-O-methyl-D-glucose (3MG) transport 219 
3MG transport assay was performed as we described previously [24,25].  220 
Muscles were transferred to 2 mL of KRB containing 1 mmol/L [3H]3-MG (1.5 µCi/ 221 
mL) (American Radiolabeled Chemicals, St. Louis, MO) and 7 mmol/L 222 
D-[1-14C]mannitol (0.3 µCi/ mL) (American Radiolabeled Chemicals, St. Louis, MO) 223 
at 30°C and further incubated for 10 min.  The muscles were then blotted onto filter 224 
paper, trimmed, frozen in liquid nitrogen, and stored at –80°C.  Each frozen muscle 225 
was weighed and processed by incubating them in 300 µl of 1 mol/L NaOH at 80°C 226 
for 10 min.  Digestates were neutralized with 300 µl of 1 mol/L HCl, and 227 
particulates were precipitated by centrifugation at 20,000 g for 2 min.  228 
Radioactivity in aliquots of the digested protein was determined by liquid 229 
scintillation counting for dual labels, and the extracellular and intracellular spaces 230 
were calculated [28].  231 
 232 
2.8. Statistical analysis 233 
Results are presented as means ± SE.  One-way ANOVA was used to estimate 234 
the variance of the dose-response and time-course studies (Figs. 1 and 2, Table 1), 235 
and statistical significance of difference between control and caffeine-treated groups 236 
was evaluated by Dunnet’s post hoc test.  Student’s t test was used to examine the 237 
significant differences between control and caffeine-treated groups in AMPK 238 
activity assay (Fig. 3), 3MG transport assay (Fig. 4), and analysis of GLUT4 content 239 
(Fig. 5).  Differences between groups were considered statistically significant at P 240 
< .05. 241 
242 
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3. Results 243 
 244 
3.1. Caffeine increases the phosphorylation of muscle AMPKα Thr172 and ACC Ser79 245 
in time- and dose-dependent manners 246 
In both α1 and α2 catalytic subunits, the primary site responsible for AMPK 247 
activation is the Thr172 residue [21].  To determine whether caffeine stimulation 248 
activates AMPK, we measured the degree of phosphorylation of AMPKα Thr172 by 249 
Western blot analysis using a phosphospecific antibody in muscle homogenates that 250 
had been stimulated with caffeine at 3 mmol/L for various times.  The time-course 251 
study showed that phosphorylation of AMPKα Thr172 increased within 15 min of 252 
caffeine stimulation in epitrochlearis and soleus muscles (Figs. 1A and C).  253 
Phosphorylation of ACC Ser79 displayed a pattern similar to that for AMPK 254 
phosphorylation in both muscles (Figs. 1B and D).  ACC is a downstream target of 255 
AMPK in skeletal muscle, and phosphorylation of the Ser79 site of ACC reflects total 256 
AMPK activity [29,30].  We chose a caffeine concentration of 3 mmol/L to 257 
reevaluate the results of preceding studies in which stimulation with 3-3.5 mmol/L 258 
of caffeine for 15 min failed to demonstrate an increase in AMPKα Thr172 259 
phosphorylation in incubated rat epitrochlearis [14], rat soleus [15,16] and mouse 260 
soleus [16] muscles.  We also determined the effects of 15 min of stimulation with 261 
various concentrations of caffeine.  The dose-response study revealed that 262 
phosphorylation of AMPKα Thr172 and ACC Ser79 increased at caffeine 263 
concentrations of 3 mmol/L or higher in both epitrochlearis (Figs. 2A and B) and 264 
soleus (Figs. 2C and D) muscles.  The total AMPK and ACC content of the 265 
muscles did not change during the study (Figs. 1 and 2).   266 
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 267 
3.2. Caffeine increases both AMPKα1 and AMPKα2 activities in skeletal muscles 268 
To identify which catalytic subunit is activated by caffeine, isoform-specific 269 
AMPK activity was determined in anti-α1 and anti-α2 immunoprecipitates from 270 
epitrochlearis and soleus muscles after treatment with caffeine (3 mmol/L, 15 min). 271 
We chose this stimulation protocol to reevaluate the preceding studies by Jensen et 272 
al [16], in which 3 mmol/L of caffeine stimulation for 15 min increased AMPKα1 273 
activity but not AMPKα2 activity in incubated rat soleus muscle, and that of Raney 274 
et al [19], in which stimulation with 3 mmol/L caffeine for 20 min increased 275 
AMPKα2 activity in perfused rat hindlimb muscles.  In contrast to the results of 276 
these two studies, in our study caffeine clearly increased AMPKα1 activity by 277 
2.3-fold and 1.8-fold, and AMPKα2 activity by 2.6-fold and 3.0-fold in 278 
epitrochlearis (Fig. 3A) and soleus muscle (Fig. 3B), respectively. 279 
 280 
3.3. Caffeine decreases ATP, PCr and glycogen content in skeletal muscles 281 
AMPK is activated in response to energy-depleting stresses such as muscle 282 
contraction, hypoxia, and inhibition of oxidative phosphorylation [26].  To 283 
determine whether caffeine increases AMPK activity in parallel with energy 284 
deprivation, we measured the time course of changes in the ATP, PCr and glycogen 285 
content in muscles incubated in the presence of 3 mmol/L of caffeine for up to 60 286 
min (Table 1).  In epitrochlearis muscle, the ATP content did not differ at any time 287 
during incubation, whereas the PCr content at 15, 30 and 60 min of stimulation was 288 
significantly lower than that of the control.  In soleus muscle, the ATP content at 30 289 
and 60 min of stimulation was significantly lower than that of the control, and the 290 
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PCr content was significantly decreased at 15, 30 and 60 min of caffeine incubation.  291 
Glycogen content was significantly lower at 60 min of incubation in both 292 
epitrochlearis and soleus muscles. 293 
 294 
3.4. Caffeine acutely increases insulin-independent glucose transport activity in 295 
skeletal muscles  296 
We next investigated whether the activation of AMPK in skeletal muscle by 297 
caffeine affects insulin-independent glucose transport activity.  Incubation with 3 298 
mmol/L caffeine for 15 min increased the rate of 3MG transport by 2.5-fold above 299 
the basal level in epitrochlearis (Fig. 4A) and by 2.2-fold in soleus (Fig. 4B). 300 
 301 
3.5. Caffeine does not affect GLUT4 content in skeletal muscles  302 
We investigated whether caffeine stimulation affects the GLUT4 content in 303 
skeletal muscles (Fig. 5).  Incubation with 3 mmol/L caffeine for 15 min did not 304 
change the total amount of GLUT4 protein in the epitrochlearis (control: 1.00 ± 0.10, 305 
caffeine: 1.05 ± 0.11 arbitrary units relative to the control, n=4 per group, p= .75) or 306 
soleus muscles (control: 1.00 ± 0.17, caffeine: 0.98 ± 0.03 arbitrary units relative to 307 
the control, n=4 per group, p= .92). 308 
309 
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4. Discussion 310 
 311 
Our data show three novel findings relating to the metabolic effect of caffeine on 312 
skeletal muscle.  First, caffeine had the ability to increase AMPKα Thr172 313 
phosphorylation (Figs. 1 and 2) and both AMPKα1 and α2 activities (Fig. 3).  The 314 
enhanced phosphorylation of ACC, an endogenous substrate of AMPK, (Figs. 1 and 315 
2) as well as increased 3MG transport activity (Fig. 4) is indicative of a substantial 316 
increase in AMPK activity in vivo.  Second, these effects were observed in both 317 
fast-glycolytic epitrochlearis and slow-oxidative soleus muscles, suggesting that the 318 
stimulatory effect of caffeine on AMPK is not specific to a particular muscle type.  319 
Third, caffeine-stimulated AMPK activation was associated with a reduction in the 320 
fuel status of skeletal muscle (Table 1), as with contraction-stimulated AMPK 321 
activation. 322 
The energy deprivation in our study may explain the difference between our 323 
results and those of Jensen et al [16] which demonstrated predominant activation of 324 
AMPKα1 by caffeine stimulation.  AMPKα2 has greater AMP dependence than 325 
AMPKα1 in respect of allosteric activation by AMP and covalent activation by 326 
upstream kinases [21,31], indicating that AMPKα2 is more sensitive to energy 327 
depletion than is AMPKα1.  In support of this idea, we previously demonstrated 328 
that AMPKα1, but not AMPKα2, is activated in rat epitrochlearis muscles treated 329 
with H2O2 and hypoxanthine/xanthine oxidase in the absence of an increase in AMP 330 
or a decrease in PCr content [25].  We have also shown that AMPKα1 is activated 331 
in low-intensity contracting muscle in which AMP concentration is not elevated, 332 
whereas AMPKα1 and α2 are activated in high-intensity contracting muscle, in 333 
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which the AMP concentration is significantly higher than the resting value [32].  In 334 
the present study, we found that 15 min of treatment with 3 mmol/L of caffeine 335 
significantly decreased the PCr content in both the epitrochlearis and soleus muscles 336 
(Table 1).  On the other hand, Jensen et al [16] did not detect any changes in energy 337 
status in mouse soleus muscles treated with 3 mmol/L caffeine.  Therefore, 338 
although the reasons for the difference in the results of the energy assays are 339 
unknown, the robust AMPKα2 activation in our study may be explained by a 340 
decrease in energy status induced by caffeine stimulation.   341 
The difference between our results and those of the study by Raney et al [19], 342 
who showed that caffeine increases AMPKα2 activation, may be explained by the 343 
different muscle preparations used: caffeine incubation in our study and caffeine 344 
perfusion in their study.  Because AMPKα1, but not AMPKα2, is activated 345 
immediately as a postmortem artifact during the isolation procedure [32], we 346 
measured AMPK activity after a preincubation period (40 min) that was sufficient to 347 
stabilize AMPKα1 activity at the basal level.  This method enabled us to examine 348 
the effect of caffeine on both AMPKα1 and AMPKα2 activities.  In contrast, Raney 349 
et al measured AMPK activity in muscles isolated after caffeine perfusion.  The 350 
actual AMPKα1 activity may be increased by caffeine but it may also be disturbed 351 
by additional activation during isolation, because an increase in AMPKα1 activity 352 
would be detectable only when the activation by caffeine exceeds that of the 353 
isolating stimuli. 354 
Preceding studies have shown that stimulation with 3-3.5 mmol/L caffeine for 355 
15 min enhances glucose transport without an apparent increase in AMPKα Thr172 356 
phosphorylation in incubated skeletal muscles [14-16].  However, Jensen et al [16] 357 
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found that some individual pairs of rat soleus muscles incubated with 3 mmol/L 358 
caffeine for 15 min clearly displayed greater AMPKα Thr172 phosphorylation, and 359 
they proposed that evaluation of AMPK activation by measuring AMPKα Thr172 360 
phosphorylation is prone to statistical type 2 error, which may lead to false 361 
conclusions that caffeine does not activate AMPK.  In fact, Jensen et al [16] have 362 
shown that in mice with muscle-specific expression of a dominant-negative, 363 
kinase-dead AMPK mutant (AMPK-KD), glucose transport is blocked in response to 364 
caffeine stimulation (3 mmol/L, 15 min) in isolated soleus muscles.  Thus, it is 365 
likely that AMPK is a signaling intermediary leading to caffeine-stimulated glucose 366 
transport in skeletal muscle.  We believe that we eliminated type 2 errors because 367 
of the rapid and gentle isolation procedure, which minimally stimulated AMPK, and 368 
because of sufficient preincubation, which decreased AMPK activity to a constant 369 
level.  We note that all muscle samples incubated with 3 mmol/L caffeine for 15 370 
min showed stronger Western blot signals for AMPKα Thr172 phosphorylation than 371 
control samples (data not shown). 372 
The finding that caffeine increased AMPKα Thr172 phosphorylation in 373 
epitrochlearis and soleus muscles (Figs. 1 and 2) provides evidence that caffeine 374 
induces covalent modification via upstream kinases.  The LKB1 complex is the 375 
main kinase that regulates AMPKα2 activity in mouse skeletal muscle during tetanic 376 
contraction in situ and in vitro [33].  The LKB1 complex is constitutively active 377 
and is not activated directly by AMP binding of AMP to AMPK facilitates the 378 
phosphorylation of AMPK by the LKB1 complex [34,35].  Thus, LKB1 is believed 379 
to be a crucial AMPK kinase in the response to energy deprivation in skeletal muscle 380 
during intense contraction.  In the present study, AMPK activation was 381 
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accompanied by a decrease in PCr content (Table 1), raising the possibility that 382 
LKB1 is involved in AMPKα2 activation by caffeine.  On the other hand, Jensen et 383 
al [16] have shown that caffeine-induced AMPKα1 activation and 2-deoxyglucose 384 
transport in mouse skeletal muscle is blocked by the Ca2+/calmodulin kinase kinase 385 
(CaMKK) inhibitor, STO-609.  Jensen et al [36] have also shown that STO-609 386 
inhibits activation of AMPKα1 and AMPKα2 as well as AMPKα Thr172 387 
phosphorylation in mouse skeletal muscles after a low-intensity tetanic contraction 388 
in vitro.  Thus, CaMKK might be the upstream kinase responsible for the 389 
caffeine-induced AMPKα1 activation observed in our study.   390 
Epidemiological studies show that long-term consumption of beverages 391 
containing caffeine such as coffee and green tea is associated with a reduced risk of 392 
type 2 diabetes [37-39].  Some researchers believe that caffeine reduces the risk of 393 
diabetes [37,40], although others do not [38,39].  Considering that caffeine and 394 
exercise exert similar effects in stimulating AMPK, caffeine may be the active 395 
ingredient responsible for the preventive effect of coffee and green tea on the 396 
development of type 2 diabetes.  In this context, further studies are needed to 397 
clarify whether oral administration of caffeine at a physiological dose results in 398 
AMPK activation and induces AMPK-related metabolic events, including glucose 399 
transport, in skeletal muscle. 400 
In summary, we demonstrated for the first time that caffeine increases AMPKα 401 
Thr172 phosphorylation and both AMPKα1 and α2 activities in fast- and slow-twitch 402 
skeletal muscles, and that this activation is accompanied by insulin-independent 403 
glucose transport and a reduction of muscle energy status.  We propose that, similar 404 
to exercise, caffeine can activate muscle glucose metabolism by stimulating AMPK. 405 
406 
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Legends 541 
 542 
Fig. 1. 543 
Caffeine stimulation increases phosphorylation of AMPKα Thr172 and ACC Ser79 in 544 
a time-dependent manner in rat skeletal muscles.  Isolated epitrochlearis (A and B) 545 
and soleus (C and D) muscles were incubated in the presence of 3 mmol/L caffeine 546 
for indicated times.  Muscle lysates were then analyzed for phosphorylation of 547 
AMPKα Thr172 (pAMPK; A and C) and ACC Ser79 (pACC; B and D) by Western 548 
blot analysis.  Fold increases are expressed relative to the level of muscles in the 549 
control (0 min incubation) group.  Representative immunoblots are shown.  Values 550 
are mean ± SE.  The number of muscles in each group is as follows: epitrochlearis; 551 
control (4), 15 min (4), 30 min (6), and 60 min (4), soleus; control (4) , 15 min (6), 552 
30 min (6), and 60 min (4).  *p<.05, **p<.01 vs. control. 553 
 554 
Fig. 2. 555 
Caffeine stimulation increases phosphorylation of AMPKα Thr172 and ACC Ser79 in 556 
a dose-dependent manner in rat skeletal muscles.  Isolated epitrochlearis (A and B) 557 
and soleus (C and D) muscles were incubated in the absence (Control) or presence of 558 
caffeine at indicated concentration for 15 min.  Muscle lysates were then analyzed 559 
for phosphorylation of AMPKα Thr172 (pAMPK; A and C) and ACC Ser79 (pACC; B 560 
and D) by Western blot analysis.  Fold increases are expressed relative to the level 561 
of muscles in the control group.  Representative immunoblots are shown.  Values 562 
are mean ± SE.  The number of muscles in each group is as follows: epitrochlearis; 563 
control (6), 1 mmol/L (6), 3 mmol/L (6), 6 mmol/L (8), 9 mmol/L (6) and 15 564 
  27 
mmol/L (6), soleus; control (10), 1 mmol/L (6), 3 mmol/L (14), 6 mmol/L (6), 9 565 
mmol/L (6) and 15 mmol/L (6).  *p<.05, **p<.01 vs. control. 566 
 567 
Fig. 3. 568 
Caffeine stimulation activates both AMPKα1 and AMPKα2 activity in rat skeletal 569 
muscles.  Isolated epitrochlearis (A) and soleus (B) muscles were incubated in the 570 
absence (Control) or presence of 3 mmol/L caffeine for 15 min.  Isoform-specific 571 
AMPK activity was determined in anti-AMPKα1 and -AMPKα2 572 
immunoprecipitates.  Fold increases are expressed relative to the activity of 573 
muscles in the control group.  Values are mean ± SE.  The number of muscles in 574 
each group is as follows: epitrochlearis; control (8), caffeine (8), soleus; control (6), 575 
caffeine (6).  **p<.01 vs. control. 576 
 577 
Fig. 4. 578 
Caffeine stimulation increases 3-O-methyl-D-glucose (3MG) transport in rat skeletal 579 
muscles.  Isolated epitrochlearis (A) and soleus (B) muscles were incubated in the 580 
absence (Control) or presence of 3 mmol/L caffeine for 15 min, and then 3MG 581 
transport activity was determined.  Values are mean ± SE.  The number of muscles 582 
in each group is as follows: epitrochlearis; control (6), caffeine (5), soleus; control 583 
(6), caffeine (6).  **p<.01, vs. control. 584 
 585 
Fig. 5. 586 
Caffeine stimulation does not affect GLUT4 content in skeletal muscles.  Isolated 587 
epitrochlearis (A) and soleus (B) muscles were incubated in the absence (Control) or 588 
  28 
presence of 3 mmol/L caffeine for 15 min.  Muscle lysates were then analyzed for 589 
GLUT4 content by Western blot analysis.  Fold increases are expressed relative to 590 
the level of muscles in the control group.  Representative immunoblots are shown.  591 
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